Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.
|
25152457 |
2014 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
|
19235232 |
2009 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
|
19235232 |
2009 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
|
19235232 |
2009 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme.
|
11751922 |
2002 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome.
|
11034457 |
2000 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesis.
|
11055895 |
2000 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesis.
|
11055895 |
2000 |
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Phosphoglycerate Dehydrogenase Deficiency
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Neu-Laxova syndrome
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
Biallelic pathogenic variants in either the PHGDH or PSAT1 genes have been shown to cause NLS.
|
30838783 |
2019 |
Neu-Laxova syndrome
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
The first was a stillbirth with Neu-Laxova syndrome and a homozygous mutation in PHGDH.
|
26960553 |
2016 |
Neu-Laxova syndrome
|
0.650 |
GeneticVariation
|
disease |
BEFREE |
Based on previous associations of mutations in this gene with a milder NLS phenotype, as well as cases of serine deficiency, these observations lend further support to a genotype-phenotype correlation between the degree of PHGDH inactivation and disease severity.
|
25913727 |
2015 |
Neu-Laxova syndrome
|
0.650 |
GermlineCausalMutation
|
disease |
ORPHANET |
PHGDH encodes the first enzyme in the phosphorylated pathway of de novo serine synthesis, and complete deficiency of its mouse ortholog recapitulates many of the key features of NLS.
|
24836451 |
2014 |
Neu-Laxova syndrome
|
0.650 |
Biomarker
|
disease |
BEFREE |
PHGDH encodes the first enzyme in the phosphorylated pathway of de novo serine synthesis, and complete deficiency of its mouse ortholog recapitulates many of the key features of NLS.
|
24836451 |
2014 |
Neu-Laxova syndrome
|
0.650 |
Biomarker
|
disease |
BEFREE |
The overrepresentation of TNF-308*A, LTAlpha+252*G and HLA-DRB1*03 allele carriers was found in a subgroup of sarcoidosis patients presenting with Lofgren's syndrome (LS) by comparison with the subgroup of patients without LS (NLS; phenotype frequency LS vs NLS: 68.8 vs 37.1% for TNF-308*A, 93.8 vs 66.3% for LTA+252*G and 68.8 vs 21.3% for DRB1*03).
|
15713215 |
2005 |
Neu-Laxova syndrome
|
0.650 |
Biomarker
|
disease |
CTD_human |
|
|
|
Neu-Laxova syndrome
|
0.650 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
NEU-LAXOVA SYNDROME 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.
|
25152457 |
2014 |
NEU-LAXOVA SYNDROME 1
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.
|
24836451 |
2014 |
NEU-LAXOVA SYNDROME 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.
|
24836451 |
2014 |
NEU-LAXOVA SYNDROME 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.
|
24836451 |
2014 |
NEU-LAXOVA SYNDROME 1
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.
|
25152457 |
2014 |
NEU-LAXOVA SYNDROME 1
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
|
19235232 |
2009 |